hotspot -WSS

hotspot

author：leisure time 2025-10-01 13:58:43 - browse：1652

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： When prostate cancer spreads, where it goes matters

explore

WSS

Venture capitalist Bob Kocher on the state of digital health

HIV vaccine remains elusive. Immunologists keep trying new ideas

Criminal prosecution for violating HIPAA: an emerging threat

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Addiction experts warn against a second 'war on drugs'

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

entertainment

hotspot

leisure time

In Memoriam: Notable people who died in 2023

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Guidelines to prevent youth baseball injuries need more muscle

It's time to retire 'poor historian' from clinicians' vocabularies

Psychedelics group wrestles with new pharma identity

Case highlights the risks of experimental stem cell therapy

Medical leaders decry Supreme Court decision on affirmative action

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

BioMarin wins approval for gene therapy to treat hemophilia A

With measles on the rise, a personal story of a devastating disease

knowledge

Bird flu: Don't repeat Covid's 'health versus the economy' framing

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Arc Institute generative AI designs new CRISPR systems

Arc Institute generative AI designs new CRISPR systems

Data integrity in scientific journals requires "effort" by publishers, institutions

It's time to retire 'poor historian' from clinicians' vocabularies

hotspot

explore

leisure time

leisure time